Literature DB >> 1651418

Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1.

L Montross1, S Watkins, R B Moreland, H Mamon, D L Caspar, R L Garcea.   

Abstract

Polyomavirus normally assembles in the nucleus of infected mouse cells. Sf9 insect cells expressing the polyomavirus major capsid protein VP1 were examined by electron microscopy. Capsidlike particles of apparently uniform size were found in the nucleus. Immunogold electron microscopy demonstrated abundant VP1 in the cytoplasm which was not assembled into any recognizable higher-order structure. Cytoplasmic VP1 assembled after the cells were treated with the calcium ionophore ionomycin. Purified VP1 aggregates were shown by negative staining and cryoelectron microscopy to consist predominantly of particles similar to the empty T = 7 viral capsid. Thus, polyomavirus VP1 can assemble in vivo into capsids independent of other viral proteins or DNA. Nuclear assembly may result from increased available calcium in this subcellular compartment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651418      PMCID: PMC248962     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Intracellular and extracellular particles in tissue cultures inoculated with parotid-tumor agent (polyoma virus).

Authors:  W G BANFIELD; C J DAWE; D C BRINDLEY
Journal:  J Natl Cancer Inst       Date:  1959-11       Impact factor: 13.506

2.  Characterization of the DNA-binding properties of the polyomavirus capsid protein VP1.

Authors:  R B Moreland; L Montross; R L Garcea
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  Site-directed mutation affecting polyomavirus capsid self-assembly in vitro.

Authors:  R L Garcea; D M Salunke; D L Caspar
Journal:  Nature       Date:  1987 Sep 3-9       Impact factor: 49.962

4.  Calcium gradients in single smooth muscle cells revealed by the digital imaging microscope using Fura-2.

Authors:  D A Williams; K E Fogarty; R Y Tsien; F S Fay
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

5.  Missense mutations in the VP1 gene of simian virus 40 that compensate for defects caused by deletions in the viral agnogene.

Authors:  A Barkan; R C Welch; J E Mertz
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins.

Authors:  T J French; J J Marshall; P Roy
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

7.  Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus.

Authors:  L Rasmussen; J K Battles; W H Ennis; K Nagashima; M A Gonda
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

8.  Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like proteins.

Authors:  P T Loudon; P Roy
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

9.  High level expression of nonfused foreign genes with Autographa californica nuclear polyhedrosis virus expression vectors.

Authors:  V A Luckow; M D Summers
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

10.  Microtubules and desmin filaments during onset of heart hypertrophy in rat: a double immunoelectron microscope study.

Authors:  S C Watkins; J L Samuel; F Marotte; B Bertier-Savalle; L Rappaport
Journal:  Circ Res       Date:  1987-03       Impact factor: 17.367

View more
  38 in total

1.  Changing the surface of a virus shell fusion of an enzyme to polyoma VP1.

Authors:  S Gleiter; K Stubenrauch; H Lilie
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

2.  Insertion of capsid proteins from nonenveloped viruses into the retroviral budding pathway.

Authors:  N K Krishna; J W Wills
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei.

Authors:  Z Richterová; D Liebl; M Horák; Z Palková; J Stokrová; P Hozák; J Korb; J Forstová
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Identification of amino acid residues within simian virus 40 capsid proteins Vp1, Vp2, and Vp3 that are required for their interaction and for viral infection.

Authors:  Akira Nakanishi; Akiko Nakamura; Robert Liddington; Harumi Kasamatsu
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry.

Authors:  X S Chen; T Stehle; S C Harrison
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

6.  T-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles.

Authors:  E Szomolanyi-Tsuda; Q P Le; R L Garcea; R M Welsh
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

7.  Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.

Authors:  Simone Grasso; Luca Santi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-07-06

8.  Activation of DNA damage repair pathways by murine polyomavirus.

Authors:  Katie Heiser; Catherine Nicholas; Robert L Garcea
Journal:  Virology       Date:  2016-08-16       Impact factor: 3.616

9.  Polyomavirus VP1 phosphorylation: coexpression with the VP2 capsid protein modulates VP1 phosphorylation in Sf9 insect cells.

Authors:  M Li; S E Delos; L Montross; R L Garcea
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  Ganglioside GT1b is a putative host cell receptor for the Merkel cell polyomavirus.

Authors:  Kimberly D Erickson; Robert L Garcea; Billy Tsai
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.